Achieve Life Sciences director reports zero holdings

Achieve Life Sciences director Jeffrey S. Farrow has filed an initial Form 3 indicating he currently holds no company securities.

Rhea-AI Filing Summary

Achieve Life Sciences director Jeffrey S. Farrow has filed an initial Form 3 indicating he currently holds no company securities. The filing lists “No securities are beneficially owned,” with total shares following the reported status shown as 0. This establishes his baseline ownership disclosure as a director of Achieve Life Sciences.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Farrow Jeffrey S

Role Director

Type	Security	Shares	Price	Value
holding	No securities are beneficially owned	--	--	--

Holdings After Transaction: No securities are beneficially owned — 0 shares (Direct)

Key Figures

Shares beneficially owned: 0 shares

1 metrics

Shares beneficially owned 0 shares Total shares following reported status on Form 3

Key Terms

Form 3, beneficially owned, reporting person, insider ownership

4 terms

Form 3 regulatory

"Director Jeffrey S. Farrow has filed an initial Form 3"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficially owned financial

"The filing lists “No securities are beneficially owned”"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

reporting person regulatory

"The reporting person is Jeffrey S. Farrow, identified as a director"

insider ownership financial

"This Form 3 establishes Jeffrey S. Farrow’s initial insider ownership"

The percentage of a company’s stock held by people with access to inside information or control, typically officers, directors and large shareholders who work at or help run the business. It matters to investors because it shows how much “skin in the game” insiders have and can signal alignment of interests, potential for concentrated control, and effects on share liquidity—like neighbors owning most of a street, which changes how decisions are made and how easy it is for others to move in or out.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Jeffrey S. Farrow’s Form 3 for ACHV show?

Jeffrey S. Farrow’s Form 3 for ACHV shows he currently holds no securities of Achieve Life Sciences. The filing states “No securities are beneficially owned,” with total shares following the reported status listed as 0.

Who is the reporting person on this ACHV Form 3 filing?

The reporting person is Jeffrey S. Farrow, identified as a director of Achieve Life Sciences. The Form 3 records his initial ownership position in the company’s securities as required for insiders under SEC rules.

How many ACHV shares does Jeffrey S. Farrow report owning?

Jeffrey S. Farrow reports owning 0 shares of Achieve Life Sciences common stock. The transaction detail shows total shares following the reported status as “0.0000,” confirming no beneficial ownership at the time of the filing.

Is there any buy or sell transaction in this ACHV Form 3?

No buy or sell transaction is reported in this Form 3 for ACHV. The entry is a holding record only, with the security title stating “No securities are beneficially owned” and no share amount or price listed.

What is the purpose of this Form 3 for Achieve Life Sciences (ACHV)?

This Form 3 establishes Jeffrey S. Farrow’s initial insider ownership in Achieve Life Sciences as a director. It shows a baseline of zero beneficially owned securities, providing a reference point for any future Form 4 or Form 5 filings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/02/2026 - 04:10 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Farrow Jeffrey S

(Last) (First) (Middle)

22722 29TH DR. SE

SUITE 100

(Street)

BOTHELL WASHINGTON 98021

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
05/29/2026

3. Issuer Name and Ticker or Trading Symbol
ACHIEVE LIFE SCIENCES, INC. [ ACHV ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
No securities are beneficially owned	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Sandra Thomson as attorney-in-fact for Jeffrey S. Farrow	06/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)